Insulin Resistance and Insulin Sensitizers

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Hormone Research in Paediatrics

• Publication date

  2001-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000063466PMID 11684868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes.

  2009cited by this paper
• Multiple sites of insulin resistance: muscle, liver and adipose tissue.

  2009cited by this paper
• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2003cited by this paper
• Hyperglycemia and Cardiovascular Disease in Type 2 Diabetes Mellitus: Evidence-based Approach to Primary and Secondary Prevention

  2003cited by this paper
• The hormone resistin links obesity to diabetes

  2001cited by this paper
• The common Arg972 polymorphism in insulin receptor substrate‐1 causes apoptosis of human pancreatic islets

  2001cited by this paper
• A Novel Use of the Hyperinsulinemic-Euglycemic Clamp Technique to Estimate Insulin Sensitivity of Systemic Lipolysis

  2001cited by this paper
• The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans.

  2001cited by this paper
• Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity.

  2001cited by this paper
• The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells.

  2000cited by this paper
• A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.

  2000cited by this paper
• Insulin action and insulin resistance in human skeletal muscle

  2000cited by this paper
• Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

  2000cited by this paper
• Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance.

  2000cited by this paper
• Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency

  2000cited by this paper
• The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

  2000cited by this paper
• Calpain 10: the first positional cloning of a gene for type 2 diabetes?

  2000cited by this paper
• The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

  2000cited by this paper
• Pathophysiology and pharmacological treatment of insulin resistance.

  2000cited by this paper
• Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins

  2000cited by this paper
• Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.

  2000cited by this paper
• The common Arg 972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets

  2000cited by this paper
• The PPARγ2 Polymorphism Pro12Ala is Associated with Better Insulin Sensitivity in the Offspring of Type 2 Diabetic Patients

  2000cited by this paper
• Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.

  2000cited by this paper
• PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance

  1999cited by this paper
• The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.

  1999cited by this paper
• Concordance rate for Type II diabetes mellitus in monozygotic twins: actuarial analysis

  1999cited by this paper
• Hyperglycemia and cardiovascular disease in type 2 diabetes.

  1999cited by this paper
• The Role of TNF-α in Human Adipose Tissue: Prevention of Weight Gain at the Expense of Insulin Resistance?

  1999cited by this paper
• Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

  1999cited by this paper
• Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

  1999cited by this paper
• PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

  1999cited by this paper
• Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin

  1999cited by this paper
• Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.

  1999cited by this paper
• PPARgamma, the ultimate thrifty gene.

  1999cited by this paper
• Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.

  1999cited by this paper
• Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.

  1998cited by this paper
• Disruption of IRS-2 causes type 2 diabetes in mice

  1998cited by this paper
• Insulin-Stimulated Akt Kinase Activity Is Reduced in Skeletal Muscle From NIDDM Subjects

  1998cited by this paper
• Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone

  1998cited by this paper
• A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

  1998cited by this paper
• A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

  1998cited by this paper
• Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells

  1998cited by this paper
• Role of non‐esterified fatty acids in the pathogenesis of Type 2 diabetes mellitus

  1998cited by this paper
• Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.

  1998cited by this paper
• Platelet Resistance to Nitrates in Obesity and Obese NIDDM, and Normal Platelet Sensitivity to Both Insulin and Nitrates in Lean NIDDM

  1998cited by this paper
• Exercise, glucose transport, and insulin sensitivity.

  1998cited by this paper
• PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

  1998cited by this paper
• Insulin resistance and the effect of insulin on blood pressure in essential hypertension.

  1998cited by this paper
• Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM

  1997cited by this paper
• Insulin Receptor Substrate-1 Phosphorylation and Phosphatidylinositol 3-Kinase Activity in Skeletal Muscle From NIDDM Subjects After In Vivo Insulin Stimulation

  1997cited by this paper
• The insulin signalling system and the IRS proteins

  1997cited by this paper
• Troglitazone action is independent of adipose tissue.

  1997cited by this paper
• Peroxisome proliferator-activated receptors, orphans with ligands and functions.

  1997cited by this paper
• Exercise and the metabolic syndrome

  1997cited by this paper
• Differential Regulation of the p80 Tumor Necrosis Factor Receptor in Human Obesity and Insulin Resistance

  1997influential reference
• A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.

  1996cited by this paper
• Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

  1996cited by this paper
• A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2

  1996cited by this paper
• Insulin resistance and macrovascular disease

  1996cited by this paper
• Insulin receptors and insulin action

  1996cited by this paper
• UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.

  1996cited by this paper
• UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations

  1996cited by this paper
• Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.

  1996cited by this paper
• The interaction between obesity and diabetes

  1996cited by this paper
• Tumor Necrosis Factor- (cid:97) – and Hyperglycemia-induced Insulin Resistance Evidence for Different Mechanisms and Different Effects on Insulin Signaling

  1996cited by this paper
• Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.

  1996cited by this paper
• Insulin Action and Age: European Group for the Study of Insulin Resistance (EGIR)

  1996cited by this paper
• Mechanism of free fatty acid-induced insulin resistance in humans.

  1996cited by this paper
• Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.

  1995cited by this paper
• Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like Cells (*)

  1995cited by this paper
• Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle.

  1995cited by this paper
• Role of insulin resistance in the pathogenesis of NIDDM

  1995cited by this paper
• Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL KsJ-db db mice

  1995cited by this paper
• Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.

  1995cited by this paper
• Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.

  1995cited by this paper
• Pathogenesis of non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus.

  1994cited by this paper
• Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

  1994cited by this paper
• Fat metabolism in human obesity.

  1994cited by this paper
• Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity.

  1994cited by this paper
• Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

  1994cited by this paper
• Glucose fatty acid interactions and the regulation of glucose disposal

  1994cited by this paper
• Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

  1994cited by this paper
• 1 Cellular insulin action and insulin resistance

  1993cited by this paper
• Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.

  1993cited by this paper
• Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families.

  1993cited by this paper
• Cellular insulin action and insulin resistance.

  1993cited by this paper
• Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus

  1992cited by this paper
• Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM

  1992cited by this paper
• Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity.

  1992cited by this paper
• Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification.

  1992cited by this paper
• NIDDM Associated With Mutation in Tyrosine Kinase Domain of Insulin Receptor Gene

  1992cited by this paper
• Carbohydrate metabolism in non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Insulin resistance--mechanisms, syndromes, and implications.

  1991cited by this paper
• Detection of Mutations in Insulin-Receptor Gene in NIDDM Patients by Analysis of Single-Stranded Conformation Polymorphisms

  1991cited by this paper
• Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Impaired Autophosphorylation of Insulin Receptors From Abdominal Skeletal Muscles in Nonobese Subjects With NIDDM

  1991cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.

  1991cited by this paper

• Hyperbaric oxygen treatment improves pancreatic β-cell function and hepatic gluconeogenesis in STZ-induced type-2 diabetes mellitus model mice

  2022cites this paper
• The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.

  2015cites this paper
• High fat diet induced insulin resistance and elevated retinol binding protein 4 in female rats; treatment and protection with Berberis vulgaris extract and vitamin A.

  2013cites this paper
• Sleep Disorder and Cardiovascular Risk Factors among Patients with Type 2 Diabetes Mellitus

  2011cites this paper
• Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

  2010cites this paper
• Methylglyoxal and Insulin Resistance

  2008cites this paper
• Obesity and polymorphisms in genes regulating human adipose tissue

  2007cites this paper
• When and how to restore β-cell function?

  2007cites this paper
• Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children

  2007cites this paper
• The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives.

  2007cites this paper
• Síndrome Metabólica, seus fenótipos e resistência à insulina pelo HOMA-RI

  2007cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2007cites this paper
• Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat

  2007cites this paper
• [Metabolic syndrome, its phenotypes, and insulin resistance by HOMA-IR].

  2007cites this paper
• 2 Genetics of Adipose-Tissue Development and Function in Humans

  2007cites this paper
• Habitual snoring is associated with elevated hemoglobin A1c levels in non‐obese middle‐aged adults

  2006cites this paper
• 1 NUTRACEUTICALS AND THE FUTURE OF MEDICAL SCIENCE

  2006cites this paper
• Nuclear Hormone Receptor Modulators for the Treatment of Diabetes and Dyslipidemia

  2006cites this paper
• Effect of Aging on the Expression of Peroxisome Proliferator-Activated Receptor γ and the Possible Relation to Insulin Resistance

  2006cites this paper
• PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

  2006cites this paper
• PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice. Commentary

  2006cites this paper
• PPARγ and Colon and Rectal Cancer: Associations with Specific Tumor Mutations, Aspirin, Ibuprofen and Insulin-Related Genes (United States)

  2006cites this paper
• Molecular Targeting of Pancreatic Disorders

  2005cites this paper
• Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

  2005cites this paper
• Genetic polymorphisms in peroxisome proliferator‐activated receptor γ are associated with Type 2 diabetes mellitus and obesity in the Korean population

  2005cites this paper
• Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes

  2005cites this paper
• Genetic variation and statistical considerations in relation to overfeeding and underfeeding in humans.

  2004cites this paper
• Troubles respiratoires au cours du sommeil, obésité et diabète

  2004cites this paper
• Targeting Insulin Resistance and β-Cell Dysfunction: The Role of Thiazolidinediones

  2004cites this paper
• [Skin changes in diabetes mellitus].

  2004cites this paper
• DIII Domain of Calpain 10 and Cpl Towards an Understanding of Calpain 10 Function

  2004cites this paper
• Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.

  2004cites this paper
• Hautveränderungen bei Diabetes mellitus

  2004cites this paper
• Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase

  2004cites this paper
• Insulin Resistance Syndrome in Children

  2003cites this paper
• Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.

  2003cites this paper
• Sleep-disordered breathing, glucose intolerance, and insulin resistance.

  2003cites this paper
• Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha.

  2003cites this paper
• Design and synthesis of novel RXR-selective modulators with improved pharmacological profile.

  2003cites this paper
• Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.

  2003influential citation
• Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells.

  2003cites this paper
• Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.

  2003cites this paper
• Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight

  2002cites this paper
• Negative regulation of adipose-expressed galectin-12 by isoproterenol, tumor necrosis factor alpha, insulin and dexamethasone.

  2002cites this paper
• Management of Rosiglitazone-Induced Edema: Two Case Reports and a Review of the Literature

  2002cites this paper